|
1
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial- mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sethi S, Macoska J, Chen W and Sarkar FH:
Molecular signature of epithelial-mesenchymal transition (EMT) in
human prostate cancer bone metastasis. Am J Transl Res. 3:90–99.
2010.PubMed/NCBI
|
|
3
|
Biddle A, Liang X, Gammon L, Fazil B,
Harper LJ, Emich H, Costea DE and Mackenzie IC: Cancer stem cells
in squamous cell carcinoma switch between two distinct phenotypes
that are preferentially migratory or proliferative. Cancer Res.
71:5317–5326. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen C, Wei Y, Hummel M, Hoffmann TK,
Gross M, Kaufmann AM and Albers AE: Evidence for
epithelial-mesenchymal transition in cancer stem cells of head and
neck squamous cell carcinoma. PLoS One. 6:e164662011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Motoyama K, Inoue H, Nakamura Y, Uetake H,
Sugihara K and Mori M: Clinical significance of high mobility group
A2 in human gastric cancer and its relationship to let-7 microRNA
family. Clin Cancer Res. 14:2334–2340. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Belge G, Meyer A, Klemke M, Burchardt K,
Stern C, Wosniok W, Loeschke S and Bullerdiek J: Upregulation of
HMGA2 in thyroid carcinomas: A novel molecular marker to
distinguish between benign and malignant follicular neoplasias.
Genes Chromosomes Cancer. 47:56–63. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang ML, Chen CC and Chang LC: Gene
expressions of HMGI-C and HMGI(Y) are associated with stage and
metastasis in colorectal cancer. Int J Colorectal Dis.
24:1281–1286. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fusco A and Fedele M: Roles of HMGA
proteins in cancer. Nat Rev Cancer. 7:899–910. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hock R, Furusawa T, Ueda T and Bustin M:
HMG chromosomal proteins in development and disease. Trends Cell
Biol. 17:72–79. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu J, Liu Z, Shao C, Gong Y, Hernando E,
Lee P, Narita M, Muller W, Liu J and Wei JJ: HMGA2
overexpression-induced ovarian surface epithelial transformation is
mediated through regulation of EMT genes. Cancer Res. 71:349–359.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chaw SY, Majeed AA, Dalley AJ, Chan A,
Stein S and Farah CS: Epithelial to mesenchymal transition (EMT)
biomarkers - E-cadherin, beta-catenin, APC and vimentin - in oral
squamous cell carcinogenesis and transformation. Oral Oncol.
48:997–1006. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nishino J, Kim I, Chada K and Morrison SJ:
Hmga2 promotes neural stem cell self-renewal in young but not old
mice by reducing p16Ink4a and p19Arf
expression. Cell. 135:227–239. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zha L, Wang Z, Tang W, Zhang N, Liao G and
Huang Z: Genome-wide analysis of HMGA2 transcription factor binding
sites by ChIP on chip in gastric carcinoma cells. Mol Cell Biochem.
364:243–251. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dave B, Mittal V, Tan NM and Chang JC:
Epithelial-mesenchymal transition, cancer stem cells and treatment
resistance. Breast Cancer Res. 14:2022012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Copley MR, Babovic S, Benz C, Knapp DJ,
Beer PA, Kent DG, Wohrer S, Treloar DQ, Day C, Rowe K, et al: The
Lin28b-let-7-Hmga2 axis determines the higher self-renewal
potential of fetal haematopoietic stem cells. Nat Cell Biol.
15:916–925. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun M, Gomes S, Chen P, Frankenberger CA,
Sankarasharma D, Chung CH, Chada KK and Rosner MR: RKIP and HMGA2
regulate breast tumor survival and metastasis through lysyl oxidase
and syndecan-2. Oncogene. 33:3528–3537. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kong D, Su G, Zha L, Zhang H, Xiang J, Xu
W, Tang Y and Wang Z: Coexpression of HMGA2 and Oct4 predicts an
unfavorable prognosis in human gastric cancer. Med Oncol.
31:1302014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang J, Mani SA, Donaher JL, Ramaswamy S,
Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A and
Weinberg RA: Twist, a master regulator of morphogenesis, plays an
essential role in tumor metastasis. Cell. 117:927–939. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Eckert MA, Lwin TM, Chang AT, Kim J, Danis
E, Ohno- Machado L and Yang J: Twist1-induced invadopodia formation
promotes tumor metastasis. Cancer Cell. 19:372–386. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pozharskaya V, Torres-González E, Rojas M,
Gal A, Amin M, Dollard S, Roman J, Stecenko AA and Mora AL: Twist:
A regulator of epithelial-mesenchymal transition in lung fibrosis.
PLoS One. 4:e75592009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu L, Li HZ, Lu SM, Tian JJ, Ma JK, Wang
HB and Xu W: Down-regulation of TWIST decreases migration and
invasion of laryngeal carcinoma Hep-2 cells by regulating the
E-cadherin, N-cadherin expression. J Cancer Res Clin Oncol.
137:1487–1493. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang WH, Lan HY, Huang CH, Tai SK, Tzeng
CH, Kao SY, Wu KJ, Hung MC and Yang MH: RAC1 activation mediates
Twist1-induced cancer cell migration. Nat Cell Biol. 14:366–374.
2012. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang MH, Hsu DS, Wang HW, Wang HJ, Lan HY,
Yang WH, Huang CH, Kao SY, Tzeng CH, Tai SK, et al: Bmi1 is
essential in Twist1-induced epithelial-mesenchymal transition. Nat
Cell Biol. 12:982–992. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sung CO, Lee KW, Han S and Kim SH: Twist1
is up-regulated in gastric cancer-associated fibroblasts with poor
clinical outcomes. Am J Pathol. 179:1827–1838. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Valdés-Mora F, Gómez del Pulgar T, Bandrés
E, Cejas P, Ramírez de Molina A, Pérez-Palacios R, Gallego-Ortega
D, García-Cabezas MA, Casado E, Larrauri J, et al: TWIST1
overexpression is associated with nodal invasion and male sex in
primary colorectal cancer. Ann Surg Oncol. 16:78–87. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zha L, Zhang J, Tang W, Zhang N, He M, Guo
Y and Wang Z: HMGA2 elicits EMT by activating the Wnt/β-catenin
pathway in gastric cancer. Dig Dis Sci. 58:724–733. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu MZ, Yao TJ, Lee NP, Ng IO, Chan YT,
Zender L, Lowe SW, Poon RT and Luk JM: Yes-associated protein is an
independent prognostic marker in hepatocellular carcinoma. Cancer.
115:4576–4585. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mani SA, Yang J, Brooks M, Schwaninger G,
Zhou A, Miura N, Kutok JL, Hartwell K, Richardson AL and Weinberg
RA: Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis
and is associated with aggressive basal-like breast cancers. Proc
Natl Acad Sci USA. 104:10069–10074. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cheng GZ, Chan J, Wang Q, Zhang W, Sun CD
and Wang LH: Twist transcriptionally up-regulates AKT2 in breast
cancer cells leading to increased migration, invasion, and
resistance to paclitaxel. Cancer Res. 67:1979–1987. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ai L, Kim WJ, Alpay M, Tang M, Pardo CE,
Hatakeyama S, May WS, Kladde MP, Heldermon CD, Siegel EM, et al:
TRIM29 suppresses TWIST1 and invasive breast cancer behavior.
Cancer Res. 74:4875–4887. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lee KW, Sung CO, Kim JH, Kang M, Yoo HY,
Kim HH, Um SH and Kim SH: CD10 expression is enhanced by Twist1 and
associated with poor prognosis in esophageal squamous cell
carcinoma with facilitating tumorigenicity in vitro and in vivo.
Int J Cancer. 136:310–321. 2015. View Article : Google Scholar : PubMed/NCBI
|
